Impact of Burden in Caregivers of Patients Hospitalized for a Psychotic Episode: a Multicenter Study (AFP)

June 5, 2020 updated by: Januel, Centre hospitalier de Ville-Evrard, France

Family support is a positive predictor for psychiatric patients. For example, since the 1980s, it has been shown that family psychoeducation improves patient adherence to care and statistically decreases patient relapse and hospitalization rates by half, resulting in lower care costs. Yet, the stress of hospitalizing a patient, seeing the feelings of shame or guilt of caregiver and the impact on their quality of life are rarely taken into account by caregivers during the first weeks hospitalization in a patient's psychiatry.

Barrelet emphasizes the importance of organizing the meeting in the first hours of hospitalization with the family in order to strengthen the alliance, to improve communication.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

161

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Île De France
      • Neuilly Sur Marne, Île De France, France, 93330
        • Unite de Recherche Clinique

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

caregiver of patient hospitalised in psychiatry

Description

Inclusion Criteria:

  • Family members or relatives
  • Over 18 years

  • Having a relative

    • First hospitalized in psychiatry or hospitalized in psychiatry within 5 years
    • Over 18 years of age
    • Psychotic episode
    • Having been informed of their participation in this study
  • In regular contact with the patient prior to hospitalization, at least 4 hours per week.
  • French language
  • Signed written informed consent.

Exclusion Criteria:

-Psychiatric pathology of another family member than the hospitalized.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
caregivers of adult patients hospitalized in psychiatry
a face-to-face interview with a nurse and self-assessment scales.
Other: clinical assessment
assessment of caregivers suffering when a family member is hospitalized
Other Names:
  • Interview

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Center for Epidemiologic Studies-Depression scale
Time Frame: at patient admission
is a simple tool for assessing depressive symptomatology for the general population
at patient admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Zarit burden inventory
Time Frame: at patient admission
to assess burden
at patient admission
Short form 36
Time Frame: at patient admission
To assess quality of life
at patient admission
Semi-directional interview
Time Frame: At patient admission
It consists of five items: subjective feeling, quality of life, social life, mood of the caregiver.
At patient admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre hospitalier de Ville-Evrard, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2015

Primary Completion (Actual)

June 8, 2018

Study Completion (Actual)

March 27, 2020

Study Registration Dates

First Submitted

June 5, 2020

First Submitted That Met QC Criteria

June 5, 2020

First Posted (Actual)

June 9, 2020

Study Record Updates

Last Update Posted (Actual)

June 9, 2020

Last Update Submitted That Met QC Criteria

June 5, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2014-A01499-38

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on The Objective of Our Study is to Assess and Take Into Account Early on the Suffering of Family Members

Clinical Trials on clinical assessment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe